Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Natriuretic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the natriuretic effect of amiloride in individuals with hypertension, examining the ADD rs4961 genetic variant, and the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiloride (amiloride)

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Hypertension Essential, Salt Excess | Phase 3 | Status: COMPLETED